Delhi, 1 September (H.S.):

Anondita Medicare made a spectacular debut on the stock market today, delighting IPO investors with a striking surge. The company’s shares, initially issued at ₹145 during the IPO, opened on the NSE’s SME platform at ₹275.50—an incredible premium of nearly 90 percent. Buoyed by robust buying momentum, the stock surged further, hitting the upper circuit limit of ₹289.25 before closing at the same level. This remarkable performance delivered a nearly 99.5 percent return to IPO subscribers on the very first trading day, effectively doubling their initial investment.

The ₹69.5 crore IPO, open for subscription from August 22 to 26, witnessed an overwhelming response from investors, with overall subscription levels reaching 300.89 times. Reserved categories also saw impressive subscription: Qualified Institutional Buyers (QIBs) at 153.03 times, Non-Institutional Investors (NIIs) at 531.82 times, and Retail Investors at 286.20 times. Through the IPO, 47.93 lakh new shares with a face value of ₹10 each were issued. The capital raised will be deployed to acquire new equipment and machinery, meet working capital needs, and finance general corporate purposes.

Financially, Anondita Medicare’s strength is evident in its consistent growth trajectory. According to the prospectus, the company reported a net profit of ₹35 lakh in FY 2022-23, which soared to ₹3.84 crore in FY 2023-24 and further jumped to ₹16.42 crore in FY 2024-25. Revenue expanded at a compound annual growth rate of over 46 percent, reaching ₹77.13 crore. However, debt levels also climbed steadily from ₹22.66 crore at the end of FY 2022-23 to ₹27.39 crore by the end of FY 2024-25, reflecting the company’s expansion efforts.

Anondita Medicare’s roaring stock market entry signals strong investor confidence and sets the stage for an ambitious growth journey ahead.

---------------

Hindusthan Samachar / Jun Sarkar